NorthWest Biotherapeutics Inc (NWBO)

[LearningEveryTrade]

BB, RE: Adam Fraudenstein....
So, one thing that caught my attention from him... he said..."blach blah, thus failed trial"... since the Original, and as far as I know, current US FDA Primary Endpoint is PFS, the trail might fail on that. BUT, if OS can be changed in US(I believe MHRA UK has already allowed endpoint change), well, then trial might be a success.
Thing is, AF is highly connected, regardless of how you feel about him... I have made some money on RUBY, thanks to him bringing it up. (Keep your enemies closer huh? He's been right on the money for CYDY, despites some ok stock performance.)
Question becomes, does AF, from him employers who are all FDA advisors, does he know FDA will say no to endpoint change??